Literature DB >> 23455573

Randomization in clinical trials: stratification or minimization? The HERMES free simulation software.

Hélène Fron Chabouis1, Francis Chabouis, Florence Gillaizeau, Pierre Durieux, Gilles Chatellier, N Dorin Ruse, Jean-Pierre Attal.   

Abstract

OBJECTIVES: Operative clinical trials are often small and open-label. Randomization is therefore very important. Stratification and minimization are two randomization options in such trials. The first aim of this study was to compare stratification and minimization in terms of predictability and balance in order to help investigators choose the most appropriate allocation method. Our second aim was to evaluate the influence of various parameters on the performance of these techniques.
MATERIALS AND METHODS: The created software generated patients according to chosen trial parameters (e.g., number of important prognostic factors, number of operators or centers, etc.) and computed predictability and balance indicators for several stratification and minimization methods over a given number of simulations. Block size and proportion of random allocations could be chosen. A reference trial was chosen (50 patients, 1 prognostic factor, and 2 operators) and eight other trials derived from this reference trial were modeled. Predictability and balance indicators were calculated from 10,000 simulations per trial.
RESULTS: Minimization performed better with complex trials (e.g., smaller sample size, increasing number of prognostic factors, and operators); stratification imbalance increased when the number of strata increased. An inverse correlation between imbalance and predictability was observed.
CONCLUSIONS: A compromise between predictability and imbalance still has to be found by the investigator but our software (HERMES) gives concrete reasons for choosing between stratification and minimization; it can be downloaded free of charge. CLINICAL RELEVANCE: This software will help investigators choose the appropriate randomization method in future two-arm trials.

Entities:  

Mesh:

Year:  2013        PMID: 23455573     DOI: 10.1007/s00784-013-0949-8

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  42 in total

1.  Committee for Proprietary Medicinal Products (CPMP): points to consider on adjustment for baseline covariates.

Authors: 
Journal:  Stat Med       Date:  2004-03-15       Impact factor: 2.373

2.  An assessment of quality characteristics of randomised control trials published in dental journals.

Authors:  Nikolaos Pandis; Argy Polychronopoulou; Theodore Eliades
Journal:  J Dent       Date:  2010-06-09       Impact factor: 4.379

Review 3.  Design, operation, and interpretation of clinical trials.

Authors:  B L Pihlstrom; M L Barnett
Journal:  J Dent Res       Date:  2010-06-25       Impact factor: 6.116

Review 4.  Stratified randomization for clinical trials.

Authors:  W N Kernan; C M Viscoli; R W Makuch; L M Brass; R I Horwitz
Journal:  J Clin Epidemiol       Date:  1999-01       Impact factor: 6.437

5.  Sample size determination in stratified trials to establish the equivalence of two treatments.

Authors:  J M Nam
Journal:  Stat Med       Date:  1995-09-30       Impact factor: 2.373

6.  Sequential treatment allocation procedures in clinical trials--with particular attention to the analysis of results for the biased coin design.

Authors:  J Halpern; B W Brown
Journal:  Stat Med       Date:  1986 May-Jun       Impact factor: 2.373

7.  How many stratification factors are "too many" to use in a randomization plan?

Authors:  T M Therneau
Journal:  Control Clin Trials       Date:  1993-04

8.  Using a balancing procedure in multicenter clinical trials. Simulation of patient allocation based on a trial of ventilation tubes for otitis media with effusion in infants.

Authors:  M M Rovers; H Straatman; G A Zielhuis; K Ingels; G J van der Wilt
Journal:  Int J Technol Assess Health Care       Date:  2000       Impact factor: 2.188

9.  Dynamic balanced randomization for clinical trials.

Authors:  D F Signorini; O Leung; R J Simes; E Beller; V J Gebski; T Callaghan
Journal:  Stat Med       Date:  1993-12-30       Impact factor: 2.373

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

View more
  2 in total

1.  Efficacy of composite versus ceramic inlays and onlays: study protocol for the CECOIA randomized controlled trial.

Authors:  Hélène Fron Chabouis; Caroline Prot; Cyrille Fonteneau; Karim Nasr; Olivier Chabreron; Stéphane Cazier; Christian Moussally; Alexandre Gaucher; Inès Khabthani Ben Jaballah; Renaud Boyer; Jean-François Leforestier; Aurore Caumont-Prim; Florence Chemla; Louis Maman; Cathy Nabet; Jean-Pierre Attal
Journal:  Trials       Date:  2013-09-03       Impact factor: 2.279

2.  Efficacy of bone substitute material in preserving volume when placing a maxillary immediate complete denture: study protocol for the PANORAMIX randomized controlled trial.

Authors:  Christophe Rignon-Bret; Alain Hadida; Alexis Aidan; Thien-Huong Nguyen; Gerard Pasquet; Helene Fron-Chabouis; Claudine Wulfman
Journal:  Trials       Date:  2016-05-20       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.